But there are biotechnologies we can use to help space travelers now, too. Space travel is risky. When it comes down to it, a space launch essentially involves strapping humans into a capsule and ...

Adnexus Biotechnologies Inc. operates an advanced AI-driven drug discovery and development platform called SUTRA. This platform, at the forefront of technological innovation, identifies specific ...

PDMIParadigm Medical Industries, Inc. Lifeline Biotechnologies, Inc. operates as a medical technology company in the United States. Its technologies focus on prevention, early diagnosis ...

Many gene therapy start-ups and academic laboratories are turning to contract development and manufacturing organizations (CDMO), such as FUJIFILM Diosynth Biotechnologies, in order to access both ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

High cholesterol is linked to many diseases, including age-related conditions, according to Reason, CEO of Repair Biotechnologies. The company is developing first-in-class gene therapies based on ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Adaptive Biotechnologies' MRD segment continues to show strong growth, with a 36% increase in revenue and clonoSEQ test volumes. The immune medicine segment remains weak, with a 66% drop in ...

Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is exempt of filing insider holdings ...

Abolis Biotechnologies also signed a tri-party agreement with L’Oréal & Evonik to secure strategic projects from innovation to market. Abolis Biotechnologies supports chemical companies and ...

SEATTLE - Adaptive Biotechnologies (NASDAQ:ADPT) Corporation (NASDAQ:ADPT) announced today that its clonoSEQ® Assay has received In Vitro Diagnostic Regulation (IVDR) 2017/746 Class C ...

GEISMAR, La., September 05, 2024--(BUSINESS WIRE)--Spectrum Biotechnologies, LLC ("Spectrum") is pleased to announce that it has completed the acquisition of AFCO 360, LLC ("AFCO" or the "Company").